Cassy Inman, PhD
banner
thehealthynarrative.com
Cassy Inman, PhD
@thehealthynarrative.com
I write Field Notes on evidence literacy and honest health stories. Systems over willpower, primary sources only. Food-industry insider turned GLP-1 patient. Experience, not advice.
Seems like the Medicare Bridge program is working. I take this medication, and for a lot of us the barrier was never willpower, it was cost and access. Watching that door open for Medicare patients is a systems story, and it gives me real hope. #GLP1 #Zepbound
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
www.cnbc.com
September 22, 2026 at 3:23 AM
"Everyone should go up" is a forum story, not a clinical one. My new Field Note on the myth of the maximum Zepbound dose, and the two biases that build it. Experience, not advice. youtu.be/JMVOGqfJt_g #Zepbound #HealthLiteracy #Titration
The Maximum Dose Myth: A Zepbound Field Note (Read Aloud)
YouTube video by The Healthy Narrative
youtu.be
September 17, 2026 at 2:03 AM
There was a period of my life when I said "I did my own research" and meant it as a badge of honor. New Field Note, read aloud, on the difference between that and actually doing it.

youtu.be/FK5ucu2uc44

#IDidMyOwnResearch #ConfirmationBias #ScienceCommunication #TheHealthyNarrative
"I Did My Own Research" | Field Note: Read Aloud
YouTube video by The Healthy Narrative
youtu.be
September 16, 2026 at 2:27 AM
Every health story has a hero, a villain, and a victim, and someone else chose who plays which part. That's the lens behind my project, The Healthy Narrative. I posted a quick poll on my Substack: are you in my tribe? Vote and see where the story goes 🎭 #HealthStorytelling #GLP1 #GLP1Journey
Cassy Inman, PhD (@thehealthynarrative)
I experience the world through a lens of narratives and storytelling. Are you in my tribe? That’s the method behind my personal project, “The Healthy Narrative.” Every health story has a setting, c...
substack.com
September 13, 2026 at 7:46 PM
Just podcast on Substack! I tell my own weight-and-GLP-1 story, and take it apart the way I’ll take apart my guests’: who the villain really was, and what I found when I moved the pieces. No before-and-after photos. No advice. Just the story, and an honest look underneath.
My body works: a weight-and-GLP-1 story
I spent years selling the willpower story. Here's what happened when I stopped believing it.
thehealthynarrative.substack.com
September 12, 2026 at 2:48 AM
Since Zepbound, I still plate the big burrito out of habit when two tacos is what my body wants. New Field Note on interoception, and why that lag between body and mind isn't a problem: it's the healing catching up. www.thehealthynarrative.com/field-notes/...
September 10, 2026 at 5:34 PM
Perhaps this indication will help guide researchers to explore more of the genetic expressions/implications of obesity, looking at pre-clinical foreshadows, showing up long before folks see the clinical manifestations after childhood.
Although the drugs are not approved ​for use in children under 12 years, clinical guidelines allow the ⁠medications to be used for obesity in children as young as eight years ​old in certain cases. 94% of the children prescribed GLP-1s had severe obesity.
www.reuters.com/legal/litiga...
More children under 12 in US are being prescribed weight-loss drugs, study finds
Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors seek new, effective ​treatments for younger patients with obesity, acc...
www.reuters.com
September 8, 2026 at 6:00 PM
“GLP-1 agonists work by imitating a natural hormone (GLP-1) created in the small intestine in response to food intake, but there are GLP-1 receptors not only in the stomach, small intestine, colon, and pancreas — to aid in digestion — but also in the heart, kidneys, lungs, and brain.”
GLP-1 medications help millions manage diabetes — but could they also treat opioid addiction or slow Alzheimer’s? That’s what researchers at our member institutions are working to find out. This is what it looks like when academic medicine #WorksForAmerica.
Could popular weight-loss drugs help treat addiction and dementia?
Researchers are studying how GLP-1 medications affect the brain and may help with hard-to-treat behavioral health conditions.
academicmedicine.aamc.org
September 8, 2026 at 5:56 PM
Reposted by Cassy Inman, PhD
The U.S. Department of Veterans Affairs (VA) is launching a Phase 3 clinical trial to evaluate the efficacy of semaglutide for the treatment of alcohol use disorder (AUD) in adult veterans. 🔗👇
September 8, 2026 at 4:30 PM
A 12% bump in life-span is promising. It's a mouse study, but may our heath-spans receive a similar bump. I for one am hopeful that my Zepbound Rx will help contribute to a healthful, joyful, grannyhood in the decades to come. #GLP1 #WeightLoss #Aging #Longevity #Ozempic
GLP-1 Weight-Loss Drugs Can Slow Aging and Extend Life Span, Mouse Study Suggests: Older female mice—equivalent in age to 60-year-old women—given daily injections of the active ingredient in Ozempic lived about 12 percent longer than… @SmithsonianMag #GLP1 #WeightLoss #Aging #Longevity #Ozempic
GLP-1 Weight-Loss Drugs Can Slow Aging and Extend Life Span, Mouse Study Suggests
Older female mice—equivalent in age to 60-year-old women—given daily injections of the active ingredient in Ozempic lived about 12 percent longer than animals that didn't receive the drug
dlvr.it
September 6, 2026 at 11:27 PM
“THE SKINNY SHOT" WAS NEVER THE STORY
“The drugs society is calling skinny shots are turning out to be tools for staying in a healthy relationship with your own body for the long term. This includes looking after your heart and kidneys and liver and breath for the long haul.”
"The Skinny Shot" was Never the Story
I'm a food-policy PhD, a public policy scholar and narratologist who studies how health stories get told, and who gets access to healthy choices in the first place. Before academia, I spent years in.....
www.thehealthynarrative.com
September 6, 2026 at 6:06 PM
HELL IS OTHER PEOPLE
​“Obesity is one of the few chronic illnesses you cannot hide, so strangers read your body and think they already know your story.” www.thehealthynarrative.com/field-notes/... #glp-1 #obesitystigma #hellisotherpeople
THE DISEASE YOU WEAR LIKE A SHROUD
I'm a food-policy PhD, a public policy scholar and narratologist who studies how health stories get told, and who gets access to healthy choices in the first place. Before academia, I spent years in.....
www.thehealthynarrative.com
September 6, 2026 at 5:59 PM
“New research finds that people taking GLP-1 tend to spend less money grocery shopping, especially on snacks.”
Scientists at Cornell University examined the shopping habits of people after they began taking a GLP-1 drug. Compared with similar households with no reported GLP-1 use, people on GLP-1s spent less on their grocery bill, particularly on snack foods.
Ozempic Is Quietly Reshaping Our Shopping Habits
New research finds that people taking GLP-1 tend to spend less money grocery shopping, especially on snacks.
gizmodo.com
September 6, 2026 at 3:49 PM
“At the same time, Gallup points out the obesity rate among Americans fell to 36.4% in 2026, down from a record high of 39.9% in 2022, the year after GLP-1 medication Wegovy was first approved by the Food and Drug Administration to treat weight loss.”
September 6, 2026 at 3:46 PM
New from The Healthy Narrative: a podcast and a written series, both about the stories we tell about our weight, and what GLP-1 medications do to them. No before-and-after. Lived it? Come tell yours, out loud or on the page: www.thehealthynarrative.com/share-your-s...
September 6, 2026 at 12:06 AM